Global Animal Blood-Derived Protein Market Outlook: Harnessing High-Value Proteins for Feed, Food, and Biopharmaceutical Innovation

Global Leading Market Research Publisher QYResearch announces the release of its latest report "Animal Blood-Derived Protein - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Animal Blood-Derived Protein market, including market size, share, demand, industry development status, and forecasts for the next few years.

For industry stakeholders-ranging from animal nutrition formulators to biopharmaceutical developers-the central challenge lies in securing consistent, high-purity protein sources that align with both circular economy principles and evolving regulatory frameworks. Animal blood-derived protein has emerged as a strategic solution, transforming slaughterhouse byproducts into high-value functional ingredients. This market is projected to grow from an estimated US$ 407 million in 2025 to US$ 605 million by 2032, at a CAGR of 5.9%, driven by expanding applications in specialty feed, functional foods, and cell culture media.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6085105/animal-blood-derived-protein

1. Market Definition and Core Value Chain
Animal blood-derived protein refers to high-value animal-based protein obtained from blood via advanced fractionation techniques including centrifugation, membrane filtration, enzymatic hydrolysis, and spray drying. Rich in globulins, albumin, and transferrin, these products offer functional benefits such as immune modulation, growth promotion, and nutritional supplementation. The value chain is characterized by vertical integration among major processors, with raw material sourcing tied closely to meat processing facilities.

2. Segment Analysis: Plasma, Hemoglobin, and Whole Blood Proteins
The market is segmented by type into Plasma Protein Powder, Hemoglobin Powder, and Whole Blood Protein Powder. Plasma protein powder dominates the premium segment due to its high digestibility and immunoglobulin content, particularly in weanling animal diets. Hemoglobin powder, valued for its iron content, is gaining traction in pet food formulations and as a natural colorant in processed foods. Whole blood protein remains cost-competitive, especially in regions with less stringent fractionation requirements.

A key trend observed in the past six months is the increased demand for species-specific plasma proteins in aquaculture and companion animal nutrition. For instance, European feed formulators are now incorporating porcine plasma in salmonid diets to reduce reliance on fishmeal, aligning with EU sustainability directives.

3. Application Landscape: Diverging Needs Across Industries
Applications span Feed, Food, and Other (including biopharmaceuticals and microbial media). The feed segment accounts for the largest share, driven by the need for antibiotic alternatives in livestock production. In food applications, purified hemoglobin is being explored as a heme-iron fortificant in plant-based meat alternatives. In the biopharma sector, blood-derived proteins serve as critical components in cell culture media for vaccine production, a segment that has seen a 12% year-over-year increase in procurement contracts since Q4 2025.

4. Industry Structure: Global Players and Regional Dynamics
Key suppliers include Darling Ingredients, VEOS Group, APC, Lican Food, Haripro, Yeruvá S.A., Sanimax, Essentia Protein Solutions, Zhejiang Mecore Bioengineering, Anhui Runtai Feed Technology, and Linyi Jiyu Protein, among others. The competitive landscape reflects a divide between vertically integrated multinationals and specialized regional processors. In North America and Europe, consolidation is intensifying around traceability and Halal/Kosher certifications, while in Asia-Pacific, capacity expansions are focused on meeting domestic feed protein demand.

5. Technological Maturity and Process Innovation
From a technical perspective, the market is undergoing a shift from traditional thermal drying toward low-temperature enzymatic hydrolysis and ultrafiltration. These methods preserve bioactivity and enable higher-value applications. A notable challenge remains the standardization of immunoglobulin activity across batches, which has prompted several manufacturers to adopt near-infrared (NIR) spectroscopy for real-time quality control. In the past six months, at least three major EU producers have filed patents related to cold-fractionation processes that retain platelet-derived growth factors for wound-care applications, signaling convergence with advanced biomedical sectors.

6. Policy and Sustainability Drivers
Regulatory tailwinds are shaping market trajectories. The European Commission's revised Animal By-Products Regulation (EC 1069/2009) now permits broader use of hydrolyzed blood proteins in non-ruminant feed, unlocking new opportunities for processors. Similarly, in the U.S., the FDA's Center for Veterinary Medicine has issued draft guidance supporting the use of blood-derived ingredients in novel animal foods. Sustainability claims are also becoming critical: blood protein production generates 70% less carbon footprint per unit of protein compared to soybean meal imports in Europe, according to a recent LCA study cited in the QYResearch report.

7. Industry Deep Dive: Discrete vs. Process Manufacturing Dynamics
A distinguishing feature of this market lies in the operational differences between discrete manufacturing (batch-based protein fractionation) and process manufacturing (continuous centrifugation and drying lines). For biopharmaceutical-grade products, discrete manufacturing with stringent cleaning protocols is essential to meet GMP standards. Conversely, feed-grade operations increasingly adopt continuous processing to improve yield consistency and energy efficiency. This bifurcation influences capital expenditure patterns: large-scale continuous lines are being installed in Brazil and China, while modular GMP-compliant units are expanding in Ireland and Singapore to serve vaccine manufacturing clusters.

8. Exclusive Observation: The Emerging "Blood-to-Value" Model
What distinguishes forward-looking players is the adoption of a "blood-to-value" operating model-moving beyond commodity pricing to ingredient-based differentiation. This involves co-locating fractionation facilities with advanced slaughterhouses and investing in digital traceability platforms. For example, a leading European processor recently launched a blockchain-enabled platform that allows pet food brands to verify the origin and functional purity of plasma proteins, addressing premium-market demands for transparency.

9. Future Outlook (2026-2032)
With a projected CAGR of 5.9%, the animal blood-derived protein market is set to outpace general animal protein growth rates. Key inflection points include:

Expansion of cell-based meat creating demand for serum-free media components derived from blood fractions.

Regulatory harmonization in Southeast Asia enabling cross-border trade of processed animal proteins.

Advancements in proteomics enabling the isolation of specific immune-modulating peptides for functional foods.

As the industry matures, stakeholders must navigate trade-offs between cost efficiency and functional value, with differentiation increasingly rooted in process technology, application-specific formulations, and sustainability credentials.

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.